Colombia Advances in the Manufacture of Medical Devices
In today's global healthcare landscape, medical devices play a central role. Not only are they essential to modern healthcare systems, but they also represent a strategic industrial sector with enormous potential for growth and innovation. From medical technology to digital health, this is a field where constant advancement defines the pace of development.
In this context, Colombia is positioning itself as a rising player in Latin America, gaining traction among both national and international investors. But what is the country doing to stand out in this industry? And why could investing in Colombia be a strategic decision for your business? Below, we explore the key factors behind Colombia's growing leadership in the medical device industry and the medtech ecosystem.
The Global and National Outlook for Medical Devices
The global context could not be more favorable. Worldwide medical device sales are projected to grow from USD 485 billion in 2022 to more than USD 660 billion by 2027.
This expansion is driven by several key trends, including advances in medical technology and the ongoing digitization of the healthcare sector—particularly through the adoption of digital tools based on artificial intelligence and big data.
Within this global framework, demand is especially strong for diagnostic imaging devices, orthopedic products, prosthetics, surgical instruments, and other types of medical equipment.
Aligned with this global momentum, Colombia has been actively strengthening its own medical device industry on multiple fronts. One of the most evident indicators is the sustained growth of the market: local sales are expected to increase from USD 1,164 million in 2018 to over USD 2 billion by 2028. Today, the sector is already valued at USD 1,728 million, making Colombia the third-largest medical device market in Latin America.

The Internal Dynamics of the Sector in Colombia
This internal dynamism has been supported by a robust and increasingly efficient regulatory framework. The National Institute for Drug and Food Surveillance (Invima)—recognized across the region for its credibility and technical rigor—has made significant progress in monitoring and regulating the medical equipment industry.
Among the most notable achievements are reductions in certification processing times, the modernization of control platforms, and a stronger focus on sanitary safety. Alongside Invima, institutions like the Ministry of Health and the Superintendence of Health Services, contribute to a regulatory ecosystem that offers transparency, reliability, and confidence to all sector stakeholders.
A key milestone in this effort is Decree 4725 of 2005, which sets the rules for the registration, marketing, and oversight of medical devices in Colombia. This legislation provides a clear and stable operational framework—an important advantage for investors seeking legal certainty in the healthcare innovation landscape.
In addition to its strong regulatory foundation, Colombia also boasts considerable manufacturing capacity. As of June 2024, there are 560 certified manufacturing establishments operating under sanitary conditions, according to the Ministry of Health. This figure reflects not only the sector’s production potential but also its ability to meet national and international quality standards in biomedical equipment technology and hospital technology.

A Favorable Climate for Investment and Trade
Colombia’s strong fundamentals have not gone unnoticed. Leading international companies like Abbott, Johnson & Johnson, Medtronic, and Renal Care Services have already established operations in the country. In fact, Renal Care Services shared their experience on our podcast Why Colombia, highlighting the competitive advantages the country offers for health sector investment. Listen to the episode here.
The presence of these global players does more than validate Colombia’s appeal as a business destination—it also helps strengthen the broader ecosystem by encouraging local partnerships, transferring knowledge and technology, and generating skilled employment opportunities.
Moreover, Colombia offers a series of strategic advantages for companies looking to export or expand their regional presence. Its privileged geographic location allows for efficient distribution throughout Latin America, while its extensive network of trade agreements enables preferential access to a wide range of international markets. Combined with the availability of high-quality human capital at competitive costs, Colombia presents a rare balance of efficiency and affordability that few countries in the region can match.

A Country Full of Opportunities
Colombia’s medical device industry offers a broad and diverse range of investment opportunities. Investors can engage in the production of inputs or finished goods across different technological levels, establish research and development centers or specialized research centers in Colombia, set up logistics hubs to serve regional markets, or even launch device clinics or healthcare institutions that use locally manufactured technologies and electronic health devices.
Colombia is building a strong foundation for the medtech sector—where market expansion, regulatory clarity, industrial capacity, institutional credibility, and the involvement of top global companies all converge.
Investing in this industry is not only a smart business move, it’s also a meaningful way to support the region’s healthcare infrastructure and bring innovation to millions of people.
Those who invest in Colombia will find a country on the move: committed to innovation, equipped with skilled talent, and guided by a long-term vision. The medical device sector offers excellent growth prospects.
Explore investment opportunities in the country of beauty on our official our official platform.